Max Rohde is first author on new gene therapy research paper
PhD candidate Max Rohde is first author on “Practical and Statistical Considerations for the Long Term Follow-Up of Gene Therapy Trial Participants” published recently in Clinical Pharmacology & Therapeutics. The paper outlines “some of the key considerations for designing long term follow-up protocols in the gene therapy setting” and offers “guidance for innovative operational and statistical methods that can help assess the safety profile and durability of response for these novel therapeutics.” Co-authors include Seoan Huh (Pfizer), Vanessa D’Souza (Google), Steven Arkin (Pfizer), Erika Roberts (ELR Lab Services), and Avery McIntosh (Pfizer).
Max’s research interests include adaptive clinical trial design, reproducible research, and statistics education. He was the 2022 winner of the Distinguished Teaching Assistant award.
